What is the market capitalization of Genenta Science S.p.A.?

Genenta Science S.p.A. (GNTA) has a market capitalization of approximately 49,777,052 USD.

Where can I buy GNTA in Canada?

GNTA can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

GNTA

Genenta Science S.p.A.

Genenta Science S.p.A. (GNTA) is an Italy company in the healthcare sector, listed on NASDAQ. Market capitalization of 50 million USD (micro-cap).

Details

Price2.11 USD

Market cap49.78 M USD

Payout ratio0.00%

ROE-38.03%

Debt / Equity34.81%

SectorHealthcare

Websitegenenta.com

Updated a few minutes ago

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.